Nuveen’s Lantern Pharma LTRN Stock Holding History

Nuveen’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.45K	Buy	+4,102	New	+$9.9K	﹤0.01%	4703

Other funds holding LTRN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Entrust Financial Wayne, Pennsylvania $205M AUM 12.8% 1-Year Est. Return

Nuveen's LTRN Position: Q3 2026 in Review

Nuveen opened a new position in Lantern Pharma (LTRN) in Q3 2026: 4,102 shares worth $4.45K. The stake represents ﹤0.01% of the portfolio and ranks #4703 among its holdings.

15 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

Nuveen held 4,102 shares of Lantern Pharma worth $4.45K as of Q3 2026.
Lantern Pharma was a new Nuveen position in Q3 2026.
Lantern Pharma made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4703 holding.
15 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.